We are live on ! Find out more
HPC

HM Payson & Co Portfolio holdings

AUM $7.54B
1-Year Est. Return 31.34%
This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+31.34%
3 Year Est. Return
+94.39%
5 Year Est. Return
+124.39%
10 Year Est. Return
+419.98%
AUM
$1.87B
AUM Growth
+$142M
Cap. Flow
-$15.9M
Cap. Flow %
-0.85%
Top 10 Hldgs %
25.97%
Holding
288
New
5
Increased
50
Reduced
166
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 13.92%
2 Industrials 13.02%
3 Technology 13.01%
4 Energy 12.65%
5 Financials 11.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
26
GE Aerospace
GE
$362B
$21.9M 1.18%
163,392
+189
+0.1% +$23.8K
ABBV icon
27
AbbVie
ABBV
$454B
$21.2M 1.14%
401,475
-7,579
-2% -$372K
WMT icon
28
Walmart Inc
WMT
$863B
$21M 1.13%
801,681
+24,465
+3% +$632K
MMM icon
29
3M
MMM
$87.5B
$20.6M 1.11%
175,989
-1,387
-0.8% -$148K
AIG icon
30
American International
AIG
$41.4B
$19.7M 1.06%
385,855
-29,043
-7% -$1.45M
JPM icon
31
JPMorgan Chase
JPM
$930B
$19.6M 1.05%
335,078
-8,361
-2% -$458K
BP icon
32
BP
BP
$113B
$18.6M 1%
467,619
-17,022
-4% -$634K
VFC icon
33
VF Corp
VFC
$6.49B
$18M 0.97%
307,186
-5,688
-2% -$296K
MRK icon
34
Merck
MRK
$322B
$17.8M 0.95%
373,205
-3,909
-1% -$179K
BAC icon
35
Bank of America
BAC
$430B
$17.4M 0.93%
1,119,174
-15,412
-1% -$229K
DEO icon
36
Diageo
DEO
$45.7B
$17.3M 0.93%
130,711
-1,886
-1% -$241K
TEVA icon
37
Teva Pharmaceuticals
TEVA
$36.3B
$15.7M 0.84%
390,515
+9,456
+2% +$372K
TPR icon
38
Tapestry
TPR
$28.1B
$15.5M 0.83%
275,577
-22,866
-8% -$1.24M
BAX icon
39
Baxter International
BAX
$11.2B
$15.4M 0.82%
407,255
+97,323
+31% +$3.53M
WMB icon
40
Williams Companies
WMB
$92B
$14.8M 0.79%
384,312
-70,165
-15% -$2.52M
PH icon
41
Parker-Hannifin
PH
$124B
$14.2M 0.76%
110,129
-25,328
-19% -$2.94M
WLY icon
42
John Wiley & Sons Class A
WLY
$2.47B
$13.9M 0.74%
250,933
-47,169
-16% -$2.38M
CMI icon
43
Cummins
CMI
$91.8B
$12.8M 0.68%
90,489
-1,540
-2% -$204K
MPC icon
44
Marathon Petroleum
MPC
$91.2B
$12.6M 0.68%
275,060
+11,152
+4% +$429K
HAS icon
45
Hasbro
HAS
$12.4B
$12.5M 0.67%
227,918
-5,192
-2% -$265K
ACN icon
46
Accenture
ACN
$84.9B
$12.5M 0.67%
151,979
+4,553
+3% +$344K
CL icon
47
Colgate-Palmolive
CL
$72.1B
$12.4M 0.67%
190,674
-3,153
-2% -$202K
VOD icon
48
Vodafone
VOD
$35.1B
$12.4M 0.66%
308,878
-4,505
-1% -$170K
SNY icon
49
Sanofi
SNY
$104B
$12.2M 0.65%
226,880
+2,183
+1% +$113K
BDX icon
50
Becton Dickinson
BDX
$42.1B
$11.9M 0.64%
110,766
-1,928
-2% -$200K

Similar funds

HM Payson & Co's Q4 2013 Portfolio in Review

As of Q4 2013, HM Payson & Co held 288 positions worth $1.87B, up 8.2% from $1.72B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 4.5%. HM Payson & Co opened 5 new positions and exited 8, leaving the 288-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Industrials and Technology.

  • HM Payson & Co's largest Q4 2013 buy was iShares MSCI KLD 400 Social ETF: 8,000 shares worth $276K.
  • HM Payson & Co added most to Danaher in Q4 2013, an estimated $7.86M increase.
  • HM Payson & Co's biggest Q4 2013 reduction was Spirit AeroSystems, cutting an estimated $7.57M.
  • HM Payson & Co fully exited Ensco Rowan plc in Q4 2013, selling an estimated $3.37M.
  • HM Payson & Co's ten largest holdings make up 26% of its $1.87B portfolio in Q4 2013.
  • HM Payson & Co opened 5 new positions and closed 8 in Q4 2013.
  • HM Payson & Co's portfolio value rose 8.2% quarter-over-quarter to $1.87B.

Based on HM Payson & Co's 13F filing for Q4 2013, filed 10 Feb 2014.